Takahata K, Monobe K, Tada M, Weber P C
Faculty of Agriculture, Okayama University, Japan.
Biosci Biotechnol Biochem. 1998 Nov;62(11):2079-85. doi: 10.1271/bbb.62.2079.
There is a growing number of animal models and clinical trials of n-3 polyunsaturated fatty acid (PUFAs) supplementation in disease. Epidemiologic and biochemical studies have suggested beneficial effects of n-3 PUFAs. But also, the use of n-3 PUFAs has some potential toxicological risks that can be circumvented by careless processing, storing, and preserving the PUFAs. The use of n-3 PUFAs is safe if appropriate preparations and dosages are selected. Much research is needed to clarify their use under different disease conditions. The newly established clinical and nutritional facts on n-3 PUFAs will induce industry to develop food products based on this knowledge.
在疾病中补充n-3多不饱和脂肪酸(PUFAs)的动物模型和临床试验数量日益增多。流行病学和生化研究表明n-3 PUFAs具有有益作用。但是,n-3 PUFAs的使用也存在一些潜在的毒理学风险,这些风险可通过对PUFAs的不当加工、储存和保存而规避。如果选择合适的制剂和剂量,n-3 PUFAs的使用是安全的。需要进行大量研究以阐明其在不同疾病状况下的应用。关于n-3 PUFAs新确立的临床和营养事实将促使食品行业基于这些知识开发相关食品。